$RGNX news
The latest RGNX stock news: headlines, filings, AI summaries and sentiment for $RGNX, updated around the clock.
- REGENXBIO Reports Q3 2026 Financial Results Amid Patent Expirations and Litigation Settlement
- Regenxbio Plans RGX-202 BLA Filing for Q1 2027 and Maintains Cash Runway Through Q4 2027
- REGENXBIO Inc. - 10-Q Filing
- REGENXBIO Inc. - 8-K Filing
- REGENXBIO Inc. - 8-K Filing
- Regenxbio Shares Rise After New Director's Stock Purchase
- REGENXBIO Inc. - 8-K Filing
- REGENXBIO Inc. - 8-K Filing
- REGENXBIO Announces Equity Offering for $100 Million
- REGENXBIO Announces $100M Common Stock Offering
- Regenxbio Shares Rise After Report FDA Will Reverse Rejection of Rare-Disease Drug
- REGENXBIO Inc. - 8-K Filing
- Regenxbio Reports Positive Phase III Data for RGX-202 Gene Therapy